| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |



From the Department of Anatomy and Cell Biology,* the University of British Columbia, Vancouver, British Columbia; and the Institut für Genetik,
Abteilung Molekulargenetik, Universität Bonn, Bonn, Germany
| Abstract |
|---|
|
|
|---|
Astrocytic gap junctions are mainly composed of the channel protein, connexin43 (Cx43).12,13 Although Cx43-deficient mice [Cx43(/)] die immediately after birth,14 heterozygous Cx43 null mice [Cx43(+/)] are viable. Cultured Cx43(+/) astrocytes exhibit reduced Cx43 protein expression and intercellular Ca2+ signaling.15,16 We have reported that Cx43(+/) mice showed significantly larger infarct volume17 and enhanced apoptosis compared to wild-type mice after middle cerebral artery (MCA) occlusion,18 demonstrating that astrocytic gap junctions may decrease apoptotic neuronal damage in ischemic brain injury.
Inflammation also plays a critical role in cerebral ischemia. Macrophages, microglia, astrocytes, and neurons can secrete various cytokines.19,20 Moreover, it has been reported that co-cultured macrophages down-regulate the expression of Cx43 in astrocytes21 and that microglia, stimulated by cytokines, express Cx43 and might communicate with astrocytes through gap junctions.22 However, the relationship between astrocytic function and inflammatory response in the pathology of the brain ischemic lesion is not yet understood.
In this study, we used mice with astrocyte-directed ablation of Cx4323 to analyze the neuroprotective role of astrocytic gap junctions in focal brain ischemia. In Cx43(+/) mice, Cx43 is compromised not only in astrocytes but also in many other cell types and organs, including the heart and vasculature. In the present study, the phenotype of mice lacking the Cx43 gene [Cx43(fl/fl), hGFAPcre] in astrocytes is independent of the decreased expression of Cx43 in other type cells, thus yielding more specific and definitive results. We demonstrate that astrocytic gap junctions play a critical role in decreasing neuronal apoptosis and inflammation after ischemic brain infarction.
| Materials and Methods |
|---|
|
|
|---|
Mice lacking Cx43 in astrocytes were generated by interbreeding mice harboring two floxed alleles of connexin43 (Cx43fl/fl)24 and mice carrying an hGFAP-cre transgene, driving cre expression in neuroglial progenitor cells.25 Parental generations used to obtain offspring for the current study were as follows: Cx43fl/fl x Cx43fl/fl, hGFAP-cre. The mice had a mixed background of 6.25% 129P2/OlaHsd; 6.25% FVB/N; 87.5% C57BL/6. In our study, we compared mice lacking Cx43 in astrocytes, denoted as Cre(+), with littermate controls, expressing both floxed Cx43 alleles in astrocytes, denoted as Cre(). Cell-type-directed excision of the Cx43 coding region led to activation of a lacZ reporter gene, embedded in the Cx43 floxed allele, in cells with Cx43 promoter activity. Therefore, cre-mediated recombination leading to loss of Cx43 expression could be monitored by X-Gal staining.23 All mice were generated and genotyped23 in the Institute of Genetics, University of Bonn, Germany.
Surgery
All procedures were approved by the Animal Care and Veterinary Services of the University of Western Ontario. Adult male Cre(+) mice (n = 10) and Cre() mice (n = 10), each weighing 30 to 40 g, were anesthetized with sodium pentobarbital (65 mg/kg i.p.). Each animal was secured to a heating pad by using surgical tape to hold the tail to the pad and the head was held securely in place using a stereotaxic frame. The rectal temperature was maintained at 37.5°C throughout the surgery and after the procedure until the animal regained consciousness. Under anesthesia, the right MCA was exposed according to a procedure described previously.18
Briefly, an incision was made on the right side of the head from the anterior of the ear to the corner of the eye horizontally and from the corner of the eye vertically 5 mm. The squamosal bone was exposed by folding the temporal muscle. By using a fine electronic-powered dental drill, a small burr hole was made
2 mm in diameter on the bone. The overlying dura mater was removed to expose the MCA. Then, the MCA was occluded above and below the rhinal fissure by using an electronic coagulator (Codman; Codman & Shurtleff Inc., Randolph, MA). After confirming no recanalization, the skin incision was closed with sutures. All animals were subsequently given free access to water and food.
Histological Analysis
Four days after surgery, animals were placed under deep anesthesia with an overdose of sodium pentobarbital (130 mg/kg i.p.) and perfused transcardially first with 10 mmol/L phosphate-buffered saline (PBS), pH 7.4, and then with 4% paraformaldehyde, pH 7.4, in PBS. The brains were removed and fixed in 4% paraformaldehyde and cryoprotected in 20% sucrose in PBS. For the immunohistochemical staining with CD11b antibody (Pharmingen, San Diego, CA), brains were removed and cryoprotected without fixation. Coronal sections were cut with a cryostat microtome at a thickness of 20 µm for measuring the infarct volume and 7 µm for terminal dUTP nick-end labeling (TUNEL) and immunohistochemical staining.
Measurement of Stroke Volume
The brain slices were mounted sequentially onto glass microscope slides and stained with thionin to allow measurement of infarct size as previously described.17,18 Damage was assessed by using a Leitz Diaplan microscope with high-power magnification (x16). Pictures of the brain sections were taken with a digital camera at x1.6 power magnification and analyzed with a computer-assisted image analysis system (SigmaScan Pro, version 4; SSPS Inc., Chicago, IL). The infarct areas in each section were measured by subtracting the remaining area of the lesioned ipsilateral hemisphere from the contralateral hemisphere. The areas of infarction on each slice were summed and multiplied by slice thickness to give the volume of infarction.
TUNEL Staining
TUNEL staining was performed according to protocol of the Apoptosis Detection System, Fluorescein (Promega, Madison, WI). Briefly, brain sections (7 µm thickness) mounted on glass slides were rehydrated and washed in 0.85% NaCl for 5 minutes and in PBS for 5 minutes. Then, sections were fixed in 4% paraformaldehyde for 15 minutes, washed in PBS, and incubated with 20 µg/ml proteinase K solution for 10 minutes. After washing in PBS, sections were postfixed in 4% paraformaldehyde for 5 minutes. Equilibration buffer was added onto the slides, then 10 minutes later, TdT enzyme and nucleotide mix were added and incubated for 1 hour at 37°C. The reaction was stopped with 2x standard saline citrate. The slides were washed and counterstained with propidium iodide. The sections were examined under a photomicroscope (Zeiss Axiophot; Carl Zeiss, New York, NY). TUNEL-stained cells were counted and averaged from six randomly picked 0.09-mm2 areas in the ischemic penumbra at the level of the brain sections shown in the third row of Figure 1A
.
|
Brain sections (7 µm thickness) were mounted on glass slides and were blocked with 10% goat serum, 1% bovine serum albumin, and 0.3% Tween 20 in PBS for 1 hour at room temperature. The sections were then incubated with ß-gal (Promega), Cx43 (Sigma, St. Louis, MO), Cx30 (Zymed, South San Francisco, CA), Cx26 (Zymed), cleaved caspase-3 (Cell Signaling, Beverly, MA), CD11b, and glial fibrillary acidic protein (GFAP; Sigma) antibodies (dilution was 1:250, 1:1000, 1:500, 1:500, 1:100, 1:50, and 1:1000, respectively) in 1% bovine serum albumin and 0.3% Tween 20 in PBS. After washing in PBS, sections were reacted with appropriate secondary antibodies (Alexa Fluor; Molecular Probes Inc., Eugene, OR) in 1% bovine serum albumin and 0.3% Tween 20 in PBS for 1 hour. Counter staining of nuclei was visualized by Hoechst 33342 (Sigma). The sections were observed under a photomicroscope (Zeiss Axiophot).
Measurement of Immunoreactivity
In this study, we focused on the lesions of interest as the cortex within the range of 400 µm from the edge of the necrotic region. All of the following assessments were performed at the level of the brain sections shown in the third row of Figure 1A
.
The cleaved caspase-3-immunoreactive cells were counted and averaged in four different randomly selected areas (300 µm x 300 µm square) from the penumbra in each mouse. Cx30-immunoreactive plaques were counted in four different randomly selected areas (300 µm x 300 µm square) from both the contralateral hemisphere cortex and the penumbral cortex in each mouse. The number of CD11b-immunoreactive cells was counted in three different x200 microscopic fields, randomly selected from the penumbra in each mouse brain. Then, the numbers were statistically evaluated in each group.
Measurement of Astrogliosis
The area of astrogliosis on the cortex was determined between the edge of necrosis and the edge of astrogliosis where the reactive astrocytes were sparsely observed.26
The measurement was performed in three different randomly selected cortical lesions in each mouse. We have, however, estimated the total gliosis volume using the obtained data. The shape of lesion was assumed to be hemispherical. Then we used the formula, Gv = 2/3
[(3
3Sv/2
) + r]3; Gv is gliosis volume, Sv is infarct volume and r is the width of gliosis. The results were statistically averaged in each group.
Statistics
All data are presented as mean ± SEM values for each group of mice. To compare mean values in two separate groups, we used unpaired t-test. Values of P < 0.05 were considered to be significant.
| Results |
|---|
|
|
|---|
Cre() mice harbor two floxed Cx43 alleles without the hGFAP-cre transgene, so that their astrocytes continuously express Cx43. On the other hand, Cre(+) mice carry the floxed Cx43 alleles and the hGFAP-cre recombinase, resulting in loss of Cx43 in the cells that express hGFAP-cre and Cx43, ie, astrocytes.23 As expected, astrocytes in Cre() mice expressed Cx43 in their membrane and cytosol but Cre(+) brains showed strongly reduced Cx43 immunoreactivity, supporting the previous data that Cx43 expression was significantly decreased in Cre(+) astrocytes.23
Increased Stroke Volume in Cre(+) Mice
We measured the infarct volume at 4 days after MCA occlusion in Cre() and Cre(+) mice brains to determine whether there was any difference in ischemic tolerance. A larger stroke area was observed in the brains of Cre(+) mice compared to Cre() mice (Figure 1A)
. According to the calculation of the infarct volume, Cre(+) mice showed a threefold larger volume compared to Cre() mice (Figure 1B
; 10.47 ± 1.28 mm3 and 3.69 ± 0.96 mm3, respectively).
Enhanced Apoptosis in the Penumbra of Cre(+) Mice
Apoptosis might contribute to delayed neuronal death, causing expansion of the stroke lesion.27
Our previous data showed an increased apoptotic reaction in Cx43(+/) mice in which astrocytic gap junctional communication was decreased compared to wild-type mice.18
Representative cases demonstrate that the penumbral lesion of Cre(+) mice show enhanced apoptosis compared to Cre() mice (Figure 2, A and B)
. When measured quantitatively, the number of TUNEL-positive cells per unit area in Cre(+) mice was significantly increased compared to Cre() mice (Figure 2C
; 18.25 ± 3.03 cells/0.09 mm2 and 7.50 ± 3.68 cells/0.09 mm2, respectively).
|
|
The lack of gap junctions influences the intercellular communication between astrocytes. Excitatory signals, such as Ca2+ and glutamate, can diffuse through gap junctions and regulate the neighboring astrocytic activation after ischemic injury.29,30
Therefore, we analyzed activated astrocytes to evaluate the reactive gliosis after ischemia. Results of our initial analysis of the area of astrogliosis in Cre(+) and Cre() brains are shown in Figure 4, A and B
. As seen in these representative pictures, astrogliosis appears reduced in Cre(+) cerebral cortex compared to Cre() mice. The average width of the astrogliosis was significantly smaller in Cre(+) cortex compared to Cre() cortex (Figure 4C
; 563.0 ± 55.9 µm and 1072.5 ± 134.0 µm, respectively). However, to determine whether astrogliosis is in fact reduced or if appears to change because of the ischemic core becoming larger in Cre(+) mice, we estimated the total gliosis volume. In this case we found the volume of astrogliosis for Cre() mice to be 25.29 mm3 and for Cre(+) to be 23.39 mm3. There was no statistical difference.
|
Cx30 and Cx26 are additional connexin proteins that have been shown to be expressed in astrocytic gap junctions.31-33 We determined the expression level of Cx30 and Cx26 in the astrocytes of Cre() and Cre(+) mice. We counted and averaged the number of Cx30-immunoreactive plaques in the cortex of contralateral hemisphere and the penumbral cortex of Cre(+) and Cre() mice. The number of Cx30-immunoreactive plaques was significantly increased both in the cortex of the contralateral hemisphere and in the penumbral cortex of Cre(+) mice as compared to the Cre() mice (281.4 ± 19.47 and 179.3 ± 14.04 counts/0.09 mm2 in contralateral hemisphere cortex and 282.3 ± 32.97 and 137.5 ± 14.89 counts/0.09 mm2 in penumbral cortex, respectively). The Cx26 protein level was not significantly changed both in intact cortex and penumbra (data not shown).
Amplified Inflammatory Response in Cre(+) Brain
The activity of astrocytes can influence the inflammatory response. Therefore, we observed the inflammatory reaction in the penumbral lesion using anti-CD11b antibody that reacts with the 170-kd
M subunit of Mac-1, expressed on macrophages and microglia.34
Immunohistochemical investigation clearly demonstrated the amplified microglia or macrophage migration into the penumbral lesion in Cre(+) compared to Cre() mice (Figure 5
; A to D). The number of CD11b-immunoreactive cells was counted and averaged in areas randomly selected from the penumbral lesion (Figure 5E)
. Cre(+) mice showed a significantly increased number of microglia and macrophages compared to Cre() mice (38.60 ± 9.80 and 24.29 ± 1.77 cells/x200 field, respectively).
|
| Discussion |
|---|
|
|
|---|
The Cre-recombinase, whose expression is directed by an hGFAP promoter region, recognizes loxP sites, and catalyzes the removal of the floxed Cx43 coding region in Cre(+) mice. Therefore, the expression of Cx43 is lost only in the cells that express GFAP, ie, astrocytes and ependymal cells as opposed to leptomeningeal cells and cells of the vasculature.23 Although Zhuo and colleagues25 reported that hGFAP-cre mediates deletion of floxed DNA in neurons and in oligodendrocytes as well, no ß-galactosidase, indicative of Cx43 inactivation, was observed in the neuronal marker-positive cells of the mice used in the current studies.23 Because neurons and oligodendrocytes have not been shown to express Cx43,35,36 hGFAP-cre-mediated deletion of Cx43 coding DNA is not relevant in those cell types. Therefore, the GJIC is compromised exclusively between astrocytes in Cre(+) mice.23 Previously, we performed focal brain ischemia on Cx43(+/) mice17,18 rather than Cx43(/) mice, because Cx43(/) mice die perinatally.14 In Cx43(+/) mice, although astrocytes show diminished Cx43 expression with reduced GJIC,17 the reduced expression of Cx43 is not restricted to astrocytes. Therefore, this deficiency of Cx43 in other cell types may have contributed to the observed findings. In the current study, the Cre(+) mice specifically have deficient GJIC in the astrocytes, leaving communication between other cell types unaltered.
The observation that heterozygous null mice18 and Cre(+) mice had a similar stroke volume was puzzling. The finding that wild-type mice18 had a larger stroke volume compared to Cre() mice was even more surprising, because Cre() mice carry a floxed Cx43 gene and show Cx43 expression decreased by 50% in cerebrum (M.T., unpublished data) as well as in cerebellum.23 CD-1 mice were used as subjects in the Cx43(+/) study whereas the Cre(+) and Cre() mice have a C57BL/6 background. We observed that C57BL/6 wild-type mice exhibited the same infarct volume as that of Cre() mice (unpublished data), which also had a genetic background composed mainly of C57BL/6, suggesting that the CD-1 mice, on reduction of wild-type Cx43 levels by 50%, may be more susceptible to ischemic insult as compared to C57BL/6 mice. Moreover, previous reports have demonstrated a significantly different stroke volume between different strains of wild-type mice, and variations of vascular anatomy or intrinsic factors yet to be determined were assumed to contribute to these differences.37,38
Brain injury was assessed at 4 days after stroke. After ischemic insults, focal pan-necrosis occurs immediately39 and apoptosis follows in 1 to 2 days.27 Inflammation and gliosis reach a maximum at 3 to 5 days after stroke.40 Therefore, it is reasonable to evaluate the results of apoptosis and the maximal inflammatory response at 4 days after stroke. In fact, we reported that a significant difference in apoptosis between Cx43(+/+) and Cx43(+/) mice was observed at 4 days after MCA occlusion although there was no difference at 1 day after stroke.18
In general, the penumbral lesion is defined as the region in which cerebral blood flow decreases to 20 to 40% of the normal condition and the tissue is electrically silent, but the possibility of improvement remains.41 Moreover, spreading depression that causes an increase in GFAP expression in astrocytes42 is considered a deterious factor in this lesion.41 Because our observations were focused on the alteration of astrocytes in which gap junctions were already compromised, we could not use traditional determinants of the penumbral lesion, so that we selected areas closely adjacent to the ischemic core for analysis.
Apoptosis plays a critical role in delayed neuronal death after cerebral ischemia. In general, apoptosis becomes maximal from 24 to 48 hours after an ischemic insult.27 In this study, intense apoptosis characterized by TUNEL labeling and cleaved caspase-3 immunohistochemical staining was still observed in the penumbra of Cre(+) mice at 4 days after MCA occlusion. Moreover, we observed an elevated apoptosis and caspase-3 activation only in the area of astrogliosis in both Cre() and Cre(+) mice. After an ischemic insult, astrocytic gap junctions in the core become internalized, while they remains intact at the penumbra.43 The authors of this latter study suggested that the gap junction-facilitated removal of cytotoxic substances from the penumbra counteracts an expansion of the ischemic lesion. Taken together, we can further conclude that astrocytic gap junctions composed of Cx43 may play a critical role in spatially buffering the apoptotic initiators and cytotoxic factors away from the penumbral lesion.
It is also critical to maintain the energy resources for the survival of cells in the penumbra because blood supply is dramatically reduced under ischemia. Recently, Zonta and colleagues44 reported that astrocytes can regulate arteriolar dilation by Ca2+ oscillation. Ca2+ waves can pass through gap junctions between astrocytes. Therefore, arterioles may not dilate in the Cre(+) penumbra because astrocytic gap junctions were compromised, resulting in diminished blood supply in the lesion.
We also evaluated the reactivity of astrocytes after MCA occlusion. Activated astrocytes dramatically increase the expression of GFAP.45
Using this criteria, we observed the activated astrocytes by immunostaining the tissue with a minimal amount of antibody against GFAP.26
We found that the area of astrogliosis was significantly smaller in the penumbra of Cre(+) mice as compared to Cre() mice. Meanwhile, we observed that inflammation was enhanced in the Cre(+) lesion while activated microglia and macrophages were present within the gliosis lesion in both Cre() and Cre(+) mice. In general, an ischemic insult in the central nervous system causes massive inflammation as well as gliosis. Activated astrocytes produce cytokines, such as interleukin-1, interleukin-6, interferon-
, and tumor necrosis factor-
46
and interact with inflammatory cells. Therefore, altered astrocytic gap junctions may affect astrocytic activation, causing a stronger inflammatory response. In this context, the apparently smaller gliosis observed in Cre(+) mice may suggest that the ischemic core expanded more widely into the gliosis lesion in Cre(+) than in Cre() mice. In fact, we found no statistical difference in the volume of gliosis comparing Cre(+) and Cre() mice. Thus, the apparently smaller gliosis observed in Cre(+) mice could result from the larger infarct volume. However, it has been reported that ischemic tolerance causes a stronger gliosis and milder inflammation after a second ischemia as compared to a nonischemic tolerance group.47
Further investigation may be needed to determine whether there is a smaller astrogliosis in the stroke lesion of Cx43-compromised animals.
Cx30 is another connexin expressed by astrocytes in the mature central nervous system31 and has been reported to be up-regulated twofold in Cre(+) mice.23 We also observed that the expression level of Cx30 was increased twofold in the cortex of the contralateral hemisphere. Cx30 was up-regulated to a similar extent in the penumbral cortex of Cre(+) mice, suggesting that the expression level of Cx30 was not further increased even under the ischemic stress. In previous experiments with heterozygous Cx43 null mice, we observed an up-regulation of Cx30 specifically in the lesioned area.18 Differences between the two studies might be because of selective ablation of Cx43 in astrocytes as opposed to decreased Cx43 expression in multiple cell types or because of the fact that Cx30 is already maximally up-regulated in mice lacking astrocytic Cx43. The issue of connexin up-regulation is complex: Cx43 expression has been reported to increase responding to the surrounding area of necrosis after ischemic insult.48 Different connexins may have different functions under normal and pathological conditions.35 Thus, the gap junctional function served by Cx30 may differ from that of Cx43 in an ischemic insult.
Cx43 gap junction hemichannel gating is also affected under pathological conditions. Contreras and colleagues49 reported that inhibition of glycolytic and oxidative metabolism induces Cx43 hemichannels to open while reducing GJIC between astrocytes. Astrocytic gap junction hemichannels may take up metabolic substances from the extracellular space and contribute to the maintenance of neuronal survival under ischemic conditions. Therefore, impediment or reduction of astrocytic gap junction hemichannels may decrease astrocytic neuroprotection.
Thus far, the neuroprotective role of astrocytic gap junctions is still controversial. Some reports note that astrocytic gap junctions spread the Ca2+ wave after ischemic insult causing the expansion of stroke volume,7,8 suggesting that the astrocytic gap junctions play a deleterious role in ischemic brain damage. In contrast, several reports have shown evidence for a neuroprotective role of astrocytic gap junctions. For example, astrocytic GJIC decreases neuronal vulnerability to oxidative stress10 and inhibition of gap junctions in astrocyte-neuron co-cultures increases neuronal death induced by glutamate cytotoxicity.11 Our findings that the compromised astrocytic gap junctions affect gliosis and inflammation after ischemia could illuminate an additional aspect to the neuroprotective role of astrocytic gap junctions.
In conclusion, Cre(+) mice showed a severe brain stroke lesion with amplified apoptosis and inflammation compared to Cre() mice. Because GJIC is specifically compromised in astrocytes of Cre(+) mice, astrocytes may not be able to remove cytotoxic substances and apoptosis-initiating factors from the ischemic core lesion through gap junctions. Moreover, an enhanced inflammatory response was observed in the Cre(+) mice penumbra, suggesting that GJIC between astrocytes may be important in limiting the inflammatory response after ischemic insults. The appropriate regulation of astrocytic gap junctions during ischemia may be a critical factor to enhance the neuroprotective role of astrocytes in stroke.
| Footnotes |
|---|
Supported by the Canadian Institutes of Health Research (to C.C.G.N.); the Heart and Stroke Foundation of Canada (to C.C.G.N.); the Canadian Stroke Network (to C.C.G.N.); the Joint Fellowship of Canadian Institutes of Health Research/Institutes of Neuroscience, Mental Health, and Addiction (to T.N.); the Japan-Canada Program (to T.N.); the Graduiertenkolleg "Pathogenese von Krankheiten des Nervensystems" (to M.T.); and the German Research Association (SFB 400, E3) to the work in the Bonn laboratory.
C.C.G.N. holds a Canada Research Chair in Gap Junctions and Disease.
Present address of M.T.: Howard Hughes Medical Institute, Center for Neurobiology and Behavior, Columbia University, 1051 Riverside Dr., New York, NY 10032.
Accepted for publication February 9, 2004.
| References |
|---|
|
|
|---|
and tumor necrosis factor-a. Proc Natl Acad Sci USA 2001, 98:4190-4195This article has been cited by other articles:
![]() |
M. A. Ozog, G. Modha, J. Church, R. Reilly, and C. C. Naus Co-administration of Ciliary Neurotrophic Factor with Its Soluble Receptor Protects against Neuronal Death and Enhances Neurite Outgrowth J. Biol. Chem., March 7, 2008; 283(10): 6546 - 6560. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. B. Francis and C. W. Lo Primordial germ cell deficiency in the connexin 43 knockout mouse arises from apoptosis associated with abnormal p53 activation Development, September 1, 2006; 133(17): 3451 - 3460. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Vetterlein, C. Muhlfeld, C. Cetegen, R. Volkmann, C. Schrader, and G. Hellige Redistribution of connexin43 in regional acute ischemic myocardium: influence of ischemic preconditioning Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H813 - H819. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Li, E. L. Hertzberg, and D. C. Spray Regulation of Connexin43-Protein Binding in Astrocytes in Response to Chemical Ischemia/Hypoxia J. Biol. Chem., March 4, 2005; 280(9): 7941 - 7948. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Ozog, S. M. Bernier, D. C. Bates, B. Chatterjee, C. W. Lo, and C. C.G. Naus The Complex of Ciliary Neurotrophic Factor-Ciliary Neurotrophic Factor Receptor {alpha} Up-Regulates Connexin43 and Intercellular Coupling in Astrocytes via the Janus Tyrosine Kinase/Signal Transducer and Activator of Transcription Pathway Mol. Biol. Cell, November 1, 2004; 15(11): 4761 - 4774. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |